Advanced CSCC

EXPERT VIDEOS

Explore medical expert insights about LIBTAYO

The following videos feature medical experts discussing pertinent topics in treating your mCSCC and laCSCC patients who are not candidates for curative surgery or curative radiation with LIBTAYO. You can learn more about advanced CSCC or dive deep into LIBTAYO clinical trial designs, results, and patient case studies.

Indications and usage

LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Identifying Patients with Advanced Cutaneous Squamous Cell Carcinoma

NEXT VIDEO
Description
Join medical oncologist Dr Ezra Cohen and surgical oncologist Dr Eric Whitman as they discuss how to identify patients with advanced CSCC who are not candidates for curative surgery or curative radiation and should be considered for consultation with a medical oncologist and systemic therapy.
Please click here for full Prescribing Information